此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Digital-Supported Versus Standard Consent for Advanced Therapeutic Endoscopy (DIGI-CONSENT)

2026年7月20日 更新者:Natalia Calo、Unity Health Toronto

Digital-Supported Versus Standard Informed Consent for Advanced Therapeutic Endoscopy: A Pragmatic Multicenter Randomized Trial

This study will evaluate whether a digital-supported informed consent process improves patient understanding before advanced therapeutic endoscopy procedures.

Patients undergoing advanced therapeutic endoscopy are often asked to make decisions about procedures that may be complex and involve important risks, benefits, and alternatives. Standard informed consent is usually provided through discussion with the treating physician. However, this process can vary between clinicians and may be affected by time pressures in busy endoscopy units.

In this study, eligible adult patients scheduled for elective advanced therapeutic endoscopy will be randomly assigned to one of two consent pathways. One group will receive standard physician-led informed consent. The other group will receive a digital-supported consent pathway that includes a standardized procedure-specific educational video, an offline artificial intelligence-based question-answering tool, and final confirmation with the treating physician before the procedure.

The digital tool is designed to provide plain-language information about the procedure, including why it is being done, expected benefits, common and serious risks, alternatives, what to expect before and after the procedure, and the patient's right to ask questions or decline the procedure. The AI question-answering tool will use only investigator-approved educational content and will not provide individualized medical advice. Questions requiring patient-specific medical judgment will be directed back to the treating clinical team.

The main outcome of the study is patient comprehension of the consent information, measured after the assigned consent process and before the procedure. The study will also evaluate patient anxiety, satisfaction, confidence in decision-making, usability of the consent process, workflow outcomes, and consent-related safety or ethical concerns.

研究概览

详细说明

This is a pragmatic multicenter randomized controlled trial evaluating digital-supported informed consent compared with standard physician-led informed consent for adults undergoing elective advanced therapeutic endoscopy.

The study will be conducted in three sequential phases. In the first phase, the digital consent tool will be developed through an iterative co-design process involving the study team, a specialist engineer, and at least one patient partner. The tool will include a standardized procedure-specific educational video and an offline artificial intelligence-based question-answering interface. The AI component will be developed using only investigator-approved educational materials, standardized consent language, and curated frequently asked questions. It will not browse the internet, retrieve external information in real time, or provide individualized medical advice.

In the second phase, a pilot study will assess feasibility, usability, acceptability, and operational performance of the digital consent pathway. The pilot will assess whether participants can access and complete the video and AI interface, whether the digital tool functions as intended, whether the survey-based outcome assessment workflow is practical, and whether refinements are needed before the full randomized trial. The pilot phase is not intended to provide definitive comparative effectiveness results.

In the third phase, the finalized intervention will be evaluated in a multicenter, parallel-group randomized controlled trial. Eligible participants will be randomized in a 1:1 ratio to either standard physician-led informed consent or the digital-supported consent pathway. Randomization will be centralized and concealed using a secure web-based system, with stratification by site and potentially by major procedure category.

Participants assigned to the standard consent arm will receive the usual physician-led informed consent process according to local clinical practice. Participants assigned to the digital-supported arm will receive access to a procedure-specific digital consent package, ideally before the procedure. The digital package will include a standardized educational video explaining the nature of the procedure, the reason it is being performed, expected benefits, major and common risks, reasonable alternatives, what to expect before and after the procedure, and the right to ask questions or decline the procedure. After viewing the video, participants may ask questions through a secure offline AI-based interface. The tool will provide plain-language responses grounded only in pre-approved study materials and will redirect individualized or high-risk questions to the treating clinical team.

In both study arms, final procedural consent remains the responsibility of the treating physician. In the digital-supported arm, the physician will conduct a final confirmation discussion before the procedure to review unresolved questions, address individualized risks, benefits, and alternatives, confirm patient understanding, and complete standard institutional consent documentation.

The primary outcome is patient comprehension of informed consent information, assessed immediately after completion of the assigned consent pathway and before the procedure. The comprehension assessment will address key domains of informed consent, including the nature of the procedure, indication, risks, benefits, alternatives, right to ask questions or refuse, and basic expectations before and after the procedure.

Secondary outcomes include pre-procedural anxiety, satisfaction with the consent process, decisional confidence or self-efficacy, perceived usability and acceptability, perceived opportunity to ask questions, preference for future consent format, physician time spent on consent, staff time where measurable, consent-related delays, same-day cancellation or deferral due to unresolved consent concerns, and need for additional pre-procedural contact related to consent. Digital process outcomes will include video completion rate, AI tool utilization rate, number and categories of patient questions, frequency of questions escalated to clinician review, and completion of the intervention before arrival. Safety and ethical quality outcomes will include withdrawal of procedural consent after the assigned intervention, patient-reported misunderstanding, complaints related to the consent process, protocol deviations involving consent, and any adverse event judged related to misunderstanding of instructions or procedural expectations.

The study is designed to minimize collection of identifiable information. Study outcomes will be collected primarily through secure survey links, and the research dataset will not include direct identifiers such as names, dates of birth, medical record numbers, addresses, email addresses, telephone numbers, or IP addresses. Any retained AI interaction data will be anonymized and will not be linked to participant identifiers.

研究类型

介入性

注册 (估计的)

180

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • Ontario
      • Toronto、Ontario、加拿大、M5B 1W8
        • St. Michael's Hospital - Unity Health Toronto

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Adults aged 18 years or older
  • Scheduled to undergo elective advanced therapeutic endoscopy
  • Able to provide informed consent for study participation
  • Able to engage with study materials in a language supported by the site
  • Willing and able to complete study questionnaires and follow-up assessments

Exclusion Criteria:

  • Emergent or urgent procedures where the consent process cannot reasonably incorporate the study intervention
  • Inability or unwillingness to provide informed consent for study participation
  • Requirement for substitute decision-maker consent for the procedural decision itself, if this precludes meaningful use of the study intervention
  • Severe cognitive, visual, hearing, or communication limitations not adequately accommodated by site resources
  • Inability to complete the planned pre-procedural assessments
  • Prior enrollment in this study for the same procedural episode
  • Any clinical situation in which the treating endoscopist determines that study participation would be unsafe or inappropriate

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Digital-Supported Informed Consent
Participants assigned to this arm will receive a digital-supported informed consent pathway before elective advanced therapeutic endoscopy. The pathway includes a standardized procedure-specific educational video, an offline AI-based question-answering tool using investigator-approved content, and final physician confirmation before the procedure. The treating physician remains responsible for individualized risk discussion and final procedural consent.
The digital-supported informed consent pathway consists of a standardized procedure-specific educational video, an offline AI-based question-answering interface, and final physician confirmation. The video explains the nature of the procedure, indication, expected benefits, major and common risks, alternatives, what to expect before and after the procedure, and the patient's right to ask questions or decline. The AI tool provides plain-language responses based only on investigator-approved educational materials and redirects individualized or high-risk questions to the treating clinical team.
其他名称:
  • Digital consent pathway
  • Video and AI-supported consent
有源比较器:Standard Physician-Led Informed Consent
Participants assigned to this arm will receive the usual physician-led informed consent process before elective advanced therapeutic endoscopy according to local clinical practice. The treating physician will review the procedure, risks, benefits, alternatives, and patient questions, and will complete standard institutional procedural consent documentation.
The standard physician-led informed consent process consists of usual pre-procedure counseling by the treating physician according to local clinical practice. The physician discusses the procedure, indication, expected benefits, risks, alternatives, and patient questions, and completes standard institutional procedural consent documentation before the advanced therapeutic endoscopy procedure.
其他名称:
  • Usual consent
  • Standard consent process

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Patient Comprehension of Informed Consent Information
大体时间:Immediately after the assigned consent pathway and before sedation/procedure
Patient comprehension will be assessed using a structured procedure-specific comprehension instrument after the assigned consent pathway. The instrument will assess understanding of the nature of the procedure, purpose or indication, risks, benefits, alternatives, right to ask questions or refuse, and expectations before and after the procedure.
Immediately after the assigned consent pathway and before sedation/procedure

次要结果测量

结果测量
措施说明
大体时间
Pre-Procedural Anxiety
大体时间:Immediately after the assigned consent pathway and before sedation/procedure
Participant-reported anxiety after completion of the assigned consent pathway, assessed using a study questionnaire or validated anxiety measure, as finalized in the study assessment plan.
Immediately after the assigned consent pathway and before sedation/procedure
Satisfaction With Consent Process
大体时间:Immediately after the assigned consent pathway and before sedation/procedure
Participant-reported satisfaction with the assigned consent process, including perceived clarity and helpfulness of the information provided.
Immediately after the assigned consent pathway and before sedation/procedure
Decisional Confidence or Self-Efficacy
大体时间:Immediately after the assigned consent pathway and before sedation/procedure
Participant-reported confidence in the decision to proceed with the procedure and perceived ability to make an informed decision after the consent process.
Immediately after the assigned consent pathway and before sedation/procedure
Usability and Acceptability of Consent Process
大体时间:Immediately after the assigned consent pathway and before sedation/procedure
Participant-reported usability and acceptability of the assigned consent process. For participants in the digital-supported arm, this will include perceived usability and acceptability of the video and AI-based question-answering tool.
Immediately after the assigned consent pathway and before sedation/procedure
Perceived Opportunity to Ask Questions
大体时间:Immediately after the assigned consent pathway and before sedation/procedure
Participant-reported perception of whether they had adequate opportunity to ask questions and have concerns addressed during the consent process.
Immediately after the assigned consent pathway and before sedation/procedure
Preference for Future Consent Format
大体时间:Immediately after the assigned consent pathway and before sedation/procedure
Participant preference for future consent format, including whether they would prefer standard physician-led consent, digital-supported consent, or a combined approach in future procedures.
Immediately after the assigned consent pathway and before sedation/procedure
Physician Time Spent on Consent
大体时间:From start to completion of the consent process on the procedure day
Total physician time spent on the consent process, measured where feasible using workflow tracking or routine operational data.
From start to completion of the consent process on the procedure day
Consent-Related Staff Time
大体时间:From start to completion of the consent process on the procedure day
Total staff time related to the consent process, where measurable using workflow tracking or routine operational data.
From start to completion of the consent process on the procedure day
Consent-Related Delay
大体时间:Procedure day, before procedure start
Delay attributable to the consent process, measured where feasible using routine operational or workflow data.
Procedure day, before procedure start
Same-Day Cancellation or Deferral Due to Consent Concerns
大体时间:Procedure day
Proportion of participants whose procedure is canceled or deferred on the same day because of unresolved consent-related concerns.
Procedure day
Additional Pre-Procedural Contact Related to Consent
大体时间:From enrollment to procedure start
Need for additional pre-procedural contact with the clinical or research team related to consent questions or concerns.
From enrollment to procedure start
Video Completion Rate
大体时间:Before procedure start
Proportion of participants assigned to the digital-supported arm who complete the standardized procedure-specific educational video.
Before procedure start
AI Tool Utilization Rate
大体时间:Before procedure start
Proportion of participants assigned to the digital-supported arm who use the offline AI-based question-answering tool.
Before procedure start
Number and Categories of Patient Questions Asked
大体时间:Before procedure start
Number and categories of questions submitted by participants through the digital question-answering interface.
Before procedure start
Frequency of Questions Escalated to Clinician Review
大体时间:Before procedure start
Number and proportion of participant questions that are flagged as individualized, complex, high-risk, or requiring clinician review.
Before procedure start
Digital Intervention Completion Before Arrival
大体时间:Before arrival for procedure
Proportion of participants assigned to the digital-supported arm who complete the digital consent pathway before arrival for the procedure.
Before arrival for procedure
Withdrawal of Procedural Consent After Assigned Intervention
大体时间:After assigned consent pathway through procedure start
Proportion of participants who withdraw procedural consent after completing the assigned consent pathway.
After assigned consent pathway through procedure start
Questionnaire Assessing Patient Understanding
大体时间:immediately after the intervention
Participant-reported misunderstanding related to the consent information, procedure instructions, or procedural expectations identified after the procedure.
immediately after the intervention
Complaints Related to Consent Process
大体时间:immediately after the intervention
Number of participant complaints related to the consent process.
immediately after the intervention
Protocol Deviations Involving Consent
大体时间:From enrollment through study follow-up
Number of protocol deviations related to delivery or documentation of the study consent or procedural consent process.
From enrollment through study follow-up
Adverse Events Related to Misunderstanding of Instructions or Procedural Expectations
大体时间:immediately after the intervention
Any adverse event judged to be related to misunderstanding of procedural instructions or expectations following the assigned consent pathway.
immediately after the intervention

其他结果措施

结果测量
措施说明
大体时间
Retention of Key Knowledge
大体时间:immediately after the intervention
Participant retention of key consent-related knowledge at short follow-up after the procedure.
immediately after the intervention
Subgroup Differences in Comprehension and Consent Outcomes
大体时间:immediately after the intervention
Exploratory subgroup analyses by age, education, prior endoscopy experience, digital literacy, procedure type, and site.
immediately after the intervention
Comparative Performance Across Study Settings
大体时间:immediately after the intervention
Exploratory comparison of intervention performance across North American and European participating sites.
immediately after the intervention

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Natalia Causada Calo、Division of Gastroenterology, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年9月1日

初级完成 (估计的)

2027年12月1日

研究完成 (估计的)

2028年3月1日

研究注册日期

首次提交

2026年7月11日

首先提交符合 QC 标准的

2026年7月20日

首次发布 (实际的)

2026年7月23日

研究记录更新

最后更新发布 (实际的)

2026年7月23日

上次提交的符合 QC 标准的更新

2026年7月20日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be shared because the study is designed to collect anonymous, non-identifiable survey-based data without direct participant identifiers or a participant linking log. The protocol does not include a formal plan for external sharing of participant-level data. Aggregate study results may be reported in publications and presentations.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅